Effect of alginate microencapsulation on the catalytic efficiency and in vitro enzyme-prodrug therapeutic efficacy of cytosine deaminase and of recombinant E. coli expressing cytosine deaminase

References

• Ahmedi A, Abouseoud M, Abdeltif A, Annabelle C. Effect of diffusion on discoloration of congo red by alginate entrapped turnip (Brassica rapa) peroxidase. Enzyme Res, 2015;2015:575–618.
   Google Scholar
• Amsden B. Solute diffusion in hydrogels: An examination of the retardation effect. Polym Gels Netw, 1998;6:13–43.
   Google Scholar
• Arias JL. Novel strategies to improve the anticancer action of 5-fluorouracil by using drug delivery systems. Molecules, 2008;13:2340–69.
   PubMed Web of Science ®Google Scholar
• Austin EA, Huber BE. A first step in the development of gene therapy for colorectal carcinoma: Cloning, sequencing, and expression of Escherichia coli cytosine deaminase. Mol Pharmacol, 1993;43:380–7.
   PubMed Web of Science ®Google Scholar
• Blandino A, Macias M, Cantero D. Calcium alginate gel as encapsulation matrix for coimmobilized enzyme systems. Appl Biochem Biotechnol, 2003;110:53–60.
   PubMed Web of Science ®Google Scholar
• Cihova M, Altanerova V, Altaner C. Stem cell based cancer gene therapy. Mol Pharm, 2011;8:1480–7.
   PubMed Web of Science ®Google Scholar
• Cook JA, Mitchell JB. Viability measurements in mammalian cell systems. Anal Biochem, 1989;179:1–7.
   PubMed Web of Science ®Google Scholar
• Dogac YI, Cinar M, Teke M. Improving of catalase stability properties by encapsulation in alginate/Fe3O4 magnetic composite beads for enzymatic removal of H2O2. Prep Biochem Biotechnol, 2015;45:144–57.
   PubMed Web of Science ®Google Scholar
• Dursun AY, Tepe O. Internal mass transfer effect on biodegradation of phenol by Ca-alginate immobilized Ralstonia eutropha. J Hazard Mater, 2005;126:105–11.
   PubMed Web of Science ®Google Scholar
• Fink DJ, Na TY, Schultz JS. Effectiveness factor calculations for immobilized enzyme catalysts. Biotechnol Bioeng, 1973;15:879–88.
   Web of Science ®Google Scholar
• Fox ME, Lemmon MJ, Mauchline ML, Davis TO, Giaccia AJ, Minton NP, Brown JM. Anaerobic bacteria as a delivery system for cancer gene therapy: In vitro activation of 5-fluorocytosine by genetically engineered clostridia. Gene Ther, 1996;3:173–8.
   PubMed Web of Science ®Google Scholar
• Fujimori M. Genetically engineered bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients. Breast Cancer, 2006;13:27–31.
   PubMedGoogle Scholar
• Gimi B, Nemani KV. Advances in alginate gel microencapsulation of therapeutic cells. Crit Rev Biomed Eng, 2013;41:469–81.
   PubMedGoogle Scholar
• Hiemstra H, Dijkhuizen L, Harder W. Diffusion of oxygen in alginate gels related to the kinetics of methanol oxidation by immobilized hansenula-polymorpha cells. Eur J Appl Microbiol Biotechnol, 1983;18:189–96.
   Google Scholar
• Kaliberov SA, Market JM, Gillespie GY, Krendelchtchikova V, Della Manna D, Sellers JC, Kaliberova LN, Black ME, Buchsbaum DJ. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma. Gene Ther, 2007;14:1111–19.
   PubMed Web of Science ®Google Scholar
• Kaliberova LN, Della Manna DL, Krendelchtchikova V, Black ME, Buchsbaum DJ, Kaliberov SA. Molecular chemotherapy of pancreatic cancer using novel mutant bacterial cytosine deaminase gene. Mol. Cancer Ther, 2008;7:2845–54.
   Google Scholar
• Katsuragi T, Sakai T, Tonomura K. Implantable enzyme capsules for cancer chemotherapy from bakers' yeast cytosine deaminase immobilized on epoxy-acrylic resin and urethane prepolymer. Appl Biochem Biotechnol, 1987;16:61–9.
   PubMed Web of Science ®Google Scholar
• Kievit E, Bershad E, Ng E, Sethna P, Dev I, Lawrence TS, Rehemtulla A. Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug gene therapy in colon cancer xenografts. Cancer Res, 1999;59:1417–21.
   PubMed Web of Science ®Google Scholar
• Kim JH, Lee HJ, Song YS. Stem cell based gene therapy in prostate cancer. Biomed Res Int, 2014;2014:549136.
   PubMedGoogle Scholar
• Krishnamurthy NV, Gimi B. Encapsulated cell grafts to treat cellular deficiencies and dysfunction. Crit Rev Biomed Eng, 2011;39:473–91.
   PubMedGoogle Scholar
• Kunkel J, Asuri P. Function, structure, and stability of enzymes confined in agarose gels. PLoS One, 2014;9:e86785
   PubMed Web of Science ®Google Scholar
• Li C, Winnard PT, Jr, Takagi T, Artemov D, Bhujwalla ZM. Multimodal image-guided enzyme/prodrug cancer therapy. J Am Chem Soc, 2006;128:15072–3.
   PubMed Web of Science ®Google Scholar
• Li J, Jiang Z, Wu H, Long L, Jiang Y, Zhang L. Improving the recycling and storage stability of enzyme by encapsulation in mesoporous CaCO3–alginate composite gel. Comp Sci Technol, 2009;69:539–44.
   Web of Science ®Google Scholar
• Longley DB, Harkin DP, Johnston PG. 5fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer, 2003;3:330–8.
   PubMed Web of Science ®Google Scholar
• Mittal V. 2013. Encapsulation nanotechnologies. Hoboken, NJ: Wiley.
   Google Scholar
• Mullen CA, Kilstrup M, Blaese RM. Transfer of the bacterial gene for cytosine deaminase to mammalian cells confers lethal sensitivity to 5-fluorocytosine: A negative selection system. Proc Natl Acad Sci USA, 1992;89:33–7.
   PubMed Web of Science ®Google Scholar
• Nafea EH, Marson A, Poole-Warren LA, Martens PJ. Immunoisolating semi-permeable membranes for cell encapsulation: Focus on hydrogels. J Control Release, 2011;154:110–22.
   PubMed Web of Science ®Google Scholar
• Nemani KV, Ennis RC, Griswold KE, Gimi B. Magnetic nanoparticle hyperthermia induced cytosine deaminase expression in microencapsulated E. coli for enzyme–prodrug therapy. J Biotechnol, 2015;20:332–40.
   Google Scholar
• Nemunaitis J, Cunningham C, Senzer N, Kuhn J, Cramm J, Litz C, Cavagnolo R, Cahill A, Clairmont C, Sznol M. Pilot trial of genetically modified, attenuated Salmonella expressing the E. coli cytosine deaminase gene in refractory cancer patients. Cancer Gene Ther, 2003;10:737–44.
   PubMed Web of Science ®Google Scholar
• Nishiyama T, Kawamura Y, Kawamoto K, Matsumura H, Yamamoto N, Ito T, Ohyama A, Katsuragi T, Sakai T. Antineoplastic effects in rats of 5-fluorocytosine in combination with cytosine deaminase capsules. Cancer Res, 1985;45:1753–61.
   PubMed Web of Science ®Google Scholar
• Orive G, Hernandez RM, Rodriguez Gascon A, Calafiore R, Chang TM, De Vos P, Hortelano G, Hunkeler D, Lacik I, Pedraz JL. History, challenges and perspectives of cell microencapsulation. Trends Biotechnol, 2004;22:87–92.
   PubMed Web of Science ®Google Scholar
• Orive G, Santos E, Pedraz JL, Hernandez RM. Application of cell encapsulation for controlled delivery of biological therapeutics. Adv Drug Deliv Rev, 2014;6768:3–14.
   Web of Science ®Google Scholar
• Papanastasopoulos P, Stebbing J. Molecular basis of 5-fluorouracil-related toxicity: Lessons from clinical practice. Anticancer Res, 2014;34:1531–5.
   PubMed Web of Science ®Google Scholar
• Planesse C, Nativel B, Iwema T, Gasque P, Robert-Da Silva C, Viranaicken W. Recombinant human HSP60 produced in ClearColi™ BL21(DE3) does not activate the NFκB pathway. Cytokine, 2015;73:190–5.
   PubMed Web of Science ®Google Scholar
• Rooseboom M, Commandeur JN, Vermeulen NP. Enzyme-catalyzed activation of anticancer prodrugs. Pharmacol Rev, 2004;56:53–102.
   PubMed Web of Science ®Google Scholar
• Sakai T, Katsuragi T, Tonomura K, Nishiyama T, Kawamura Y. Implantable encapsulated cytosine deaminase having 5-fluorocytosine-deaminating activity. J Biotechnol, 1985;2:13–21.
   Web of Science ®Google Scholar
• Taqieddin E, Amiji M. Enzyme immobilization in novel alginate-chitosan core-shell microcapsules. Biomaterials, 2004;25:1937–45.
   PubMed Web of Science ®Google Scholar
• Tietze LF, Schmuck K. Prodrugs for targeted tumor therapies: recent developments in ADEPT, GDEPT and PMT. Curr Pharm Des, 2011;17:3527–47.
   PubMed Web of Science ®Google Scholar
• Xu G, Mcleod HL. Strategies for enzyme/prodrug cancer therapy. Clin Cancer Res, 2001;7:3314–24.
   PubMed Web of Science ®Google Scholar
• Yi BR, Kim SU, Kim YB, Lee HJ, Cho MH, Choi KC. Antitumor effects of genetically engineered stem cells expressing yeast cytosine deaminase in lung cancer brain metastases via their tumor-tropic properties. Oncol Rep, 2012;27:1823–8.
   PubMed Web of Science ®Google Scholar
• Zanna H, Nok AJ, Ibrahim S, Inuwa HM. Stabilization of Aspergillus parasiticus cytosine deaminase by immobilization on calcium alginate beads improved enzyme operational stability. J Enzyme Inhib Med Chem, 2013;28:1217–20.
   PubMed Web of Science ®Google Scholar
• Zimmermann H, Shirley SG, Zimmermann U. Alginate-based encapsulation of cells: Past, present, and future. Curr Diab Rep, 2007;7:314–20.
   PubMedGoogle Scholar